Medical Marijuana Inc (OTCMKTS:MJNA) reported that its subsidiary unit HempMeds® Mexico catched national news headlines in Mexico for the promising report of a recent trial performed by Dr. Saul Garza Morales on the impact of its RSHO-X™ offering in treating kids with severe epilepsy.
HempMeds® Mexico turns to be the first firm to receive government import approvals for its Cannabidiol oil product RSHO-X™ through the Mexican Health Department COFEPRIS. Almost 84% of kids with epilepsy cured with RSHO-X™ drug halved the count of seizures they undergo, according to the preliminary clinical trial on the application of cannabis in people with Lennox-Gastaut syndrome in Mexico.
Dr. Stuart Titus, the CEO of Medical Marijuana, reported that they are proud that that their Cannabidiol hemp oil product, in absence of THC, has enabled 17% of people in the trial to witness 100% relief from their seizures. It is the best outcome of any medication/